Lei Changzhen, Gong Daojun, Zhuang Bo, Zhang Zhiwei
Department of Gastrointestinal Surgery, Jinhua Hospital of Zhejiang University, Jinhua, China.
Front Oncol. 2022 Aug 23;12:960281. doi: 10.3389/fonc.2022.960281. eCollection 2022.
Gastric cancer (GC) is one of the leading causes of cancer mortality worldwide. Numerous studies have shown that the gastric microbiota can contribute to the occurrence and development of GC by generating harmful microbial metabolites, suggesting the possibility of discovering biomarkers. Metabolomics has emerged as an advanced promising analytical method for the analysis of microbiota-derived metabolites, which have greatly accelerated our understanding of host-microbiota metabolic interactions in GC. In this review, we briefly compiled recent research progress on the changes of gastric microbiota and its metabolites associated with GC. And we further explored the application of metabolomics and gastric microbiome association analysis in the diagnosis, prevention and treatment of GC.
胃癌(GC)是全球癌症死亡的主要原因之一。众多研究表明,胃微生物群可通过产生有害的微生物代谢产物促进胃癌的发生和发展,这提示了发现生物标志物的可能性。代谢组学已成为一种先进且有前景的分析方法,用于分析微生物群衍生的代谢产物,极大地加速了我们对胃癌中宿主-微生物群代谢相互作用的理解。在本综述中,我们简要汇总了与胃癌相关的胃微生物群及其代谢产物变化的近期研究进展。并且我们进一步探讨了代谢组学与胃微生物组关联分析在胃癌诊断、预防和治疗中的应用。